Assenagon Asset Management
VNDA icon

Assenagon Asset Management’s Vanda Pharmaceuticals VNDA Stock Holding History

Assenagon Asset Management’s Portfolio VNDA Stock Details VNDA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-730,820
Closed -$3M – 1499
2024
Q1 		$3M Sell
730,820
-856,897
-54% -$3.43M 0.01% 741
2023
Q4 		$6.7M Hold
1,587,717
– – 0.02% 555
2023
Q3 		$6.86M Hold
1,587,717
– – 0.02% 489
2023
Q2 		$10.5M Hold
1,587,717
– – 0.04% 353
2023
Q1 		$10.8M Hold
1,587,717
– – 0.04% 367
2022
Q4 		$11.7M Sell
1,587,717
-2,143
-0.1% -$20.9K 0.04% 348
2022
Q3 		$15.7M Sell
1,589,860
-936,620
-37% -$9.89M 0.06% 271
2022
Q2 		$27.5M Buy
2,526,480
+1,195,768
+90% +$12.4M 0.1% 183
2022
Q1 		$15.1M Buy
1,330,712
+878,492
+194% +$11.5M 0.04% 282
2021
Q4 		$7.09M Buy
452,220
+365,075
+419% +$6.36M 0.02% 419
2021
Q3 		$1.49M Buy
87,145
+15,270
+21% +$267K ﹤0.01% 781
2021
Q2 		$1.55M Sell
71,875
-315,730
-81% -$5.65M 0.01% 776
2021
Q1 		$5.82M Sell
387,605
-113,563
-23% -$1.84M 0.02% 468
2020
Q4 		$6.58M Buy
501,168
+39,984
+9% +$481K 0.03% 313
2020
Q3 		$4.46M Sell
461,184
-6,544
-1% -$69.9K 0.03% 359
2020
Q2 		$5.35M Buy
+467,728
New +$5.3M 0.03% 318

Other funds holding VNDA

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return
Jacobs Levy Equity Management
Jacobs Levy Equity Management Florham Park, New Jersey $23.8B AUM 25.4% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Assenagon Asset Management's VNDA Position: Q2 2024 in Review

Assenagon Asset Management sold out of Vanda Pharmaceuticals (VNDA) in Q2 2024, closing a stake of 730,820 shares — an estimated $3M sold.

Assenagon Asset Management first reported a position in VNDA in Q2 2020 and held it in 16 quarters. The position peaked at $27.5M in Q2 2022. 148 funds tracked by Wall St. Rank hold VNDA as of Q2 2024.

  • Assenagon Asset Management reported no remaining Vanda Pharmaceuticals position as of Q2 2024 after selling out during the quarter.
  • Assenagon Asset Management sold 730,820 Vanda Pharmaceuticals shares in Q2 2024, an estimated $3M.
  • Assenagon Asset Management first reported a position in Vanda Pharmaceuticals in Q2 2020 and held it in 16 quarters.
  • Assenagon Asset Management's Vanda Pharmaceuticals position peaked at $27.5M in Q2 2022.
  • 148 funds tracked by Wall St. Rank held Vanda Pharmaceuticals as of Q2 2024.

Based on Assenagon Asset Management's 13F filing for Q2 2024, filed 18 Jul 2024.